IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesiense

The management of human African trypanosomiasis (HAT) is constrained by lack of simple-to-use diagnostic, staging, and treatment tools. The search for novel biomarkers is, therefore, essential in the fight against HAT. The current study aimed at investigating the potential of IL-6 as an adjunct para...

Full description

Saved in:
Bibliographic Details
Main Authors: Dawn Nyawira Maranga, John Maina Kagira, Christopher Kariuki Kinyanjui, Simon Muturi Karanja, Naomi Wangari Maina, Maina Ngotho
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2013/320509
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557045049458688
author Dawn Nyawira Maranga
John Maina Kagira
Christopher Kariuki Kinyanjui
Simon Muturi Karanja
Naomi Wangari Maina
Maina Ngotho
author_facet Dawn Nyawira Maranga
John Maina Kagira
Christopher Kariuki Kinyanjui
Simon Muturi Karanja
Naomi Wangari Maina
Maina Ngotho
author_sort Dawn Nyawira Maranga
collection DOAJ
description The management of human African trypanosomiasis (HAT) is constrained by lack of simple-to-use diagnostic, staging, and treatment tools. The search for novel biomarkers is, therefore, essential in the fight against HAT. The current study aimed at investigating the potential of IL-6 as an adjunct parameter for HAT stage determination in vervet monkey model. Four adult vervet monkeys (Chlorocebus aethiops) were experimentally infected with Trypanosoma brucei rhodesiense and treated subcuratively at 28 days after infection (dpi) to induce late stage disease. Three noninfected monkeys formed the control group. Cerebrospinal fluid (CSF) and blood samples were obtained at weekly intervals and assessed for various biological parameters. A typical HAT-like infection was observed. The late stage was characterized by significant (P<0.05) elevation of CSF IL-6, white blood cell count, and total protein starting 35 dpi with peak levels of these parameters coinciding with relapse parasitaemia. Brain immunohistochemical staining revealed an increase in brain glial fibrillary acidic protein expression indicative of reactive astrogliosis in infected animals which were euthanized in late-stage disease. The elevation of IL-6 in CSF which accompanied other HAT biomarkers indicates onset of parasite neuroinvasion and show potential for use as an adjunct late-stage disease biomarker in the Rhodesian sleeping sickness.
format Article
id doaj-art-a7e2ea5c3e2a49e1b80448695b4fdcea
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-a7e2ea5c3e2a49e1b80448695b4fdcea2025-02-03T05:43:42ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/320509320509IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesienseDawn Nyawira Maranga0John Maina Kagira1Christopher Kariuki Kinyanjui2Simon Muturi Karanja3Naomi Wangari Maina4Maina Ngotho5Jomo Kenyatta University of Agriculture and Technology, College of Health Sciences, Biochemistry Department, P.O. Box 62000-00200, Nairobi, KenyaJomo Kenyatta University of Agriculture and Technology, College of Agriculture and Natural Resources, Animal Health and Production Department, P.O. Box 62000-00200, Nairobi, KenyaInstitute of Primate Research, Animal Science Department, P.O. Box 24481-00502, Nairobi, KenyaJomo Kenyatta University of Agriculture and Technology, College of Health Sciences, Biochemistry Department, P.O. Box 62000-00200, Nairobi, KenyaJomo Kenyatta University of Agriculture and Technology, College of Health Sciences, Biochemistry Department, P.O. Box 62000-00200, Nairobi, KenyaInstitute of Primate Research, Animal Science Department, P.O. Box 24481-00502, Nairobi, KenyaThe management of human African trypanosomiasis (HAT) is constrained by lack of simple-to-use diagnostic, staging, and treatment tools. The search for novel biomarkers is, therefore, essential in the fight against HAT. The current study aimed at investigating the potential of IL-6 as an adjunct parameter for HAT stage determination in vervet monkey model. Four adult vervet monkeys (Chlorocebus aethiops) were experimentally infected with Trypanosoma brucei rhodesiense and treated subcuratively at 28 days after infection (dpi) to induce late stage disease. Three noninfected monkeys formed the control group. Cerebrospinal fluid (CSF) and blood samples were obtained at weekly intervals and assessed for various biological parameters. A typical HAT-like infection was observed. The late stage was characterized by significant (P<0.05) elevation of CSF IL-6, white blood cell count, and total protein starting 35 dpi with peak levels of these parameters coinciding with relapse parasitaemia. Brain immunohistochemical staining revealed an increase in brain glial fibrillary acidic protein expression indicative of reactive astrogliosis in infected animals which were euthanized in late-stage disease. The elevation of IL-6 in CSF which accompanied other HAT biomarkers indicates onset of parasite neuroinvasion and show potential for use as an adjunct late-stage disease biomarker in the Rhodesian sleeping sickness.http://dx.doi.org/10.1155/2013/320509
spellingShingle Dawn Nyawira Maranga
John Maina Kagira
Christopher Kariuki Kinyanjui
Simon Muturi Karanja
Naomi Wangari Maina
Maina Ngotho
IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesiense
Clinical and Developmental Immunology
title IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesiense
title_full IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesiense
title_fullStr IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesiense
title_full_unstemmed IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesiense
title_short IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesiense
title_sort il 6 is upregulated in late stage disease in monkeys experimentally infected with trypanosoma brucei rhodesiense
url http://dx.doi.org/10.1155/2013/320509
work_keys_str_mv AT dawnnyawiramaranga il6isupregulatedinlatestagediseaseinmonkeysexperimentallyinfectedwithtrypanosomabruceirhodesiense
AT johnmainakagira il6isupregulatedinlatestagediseaseinmonkeysexperimentallyinfectedwithtrypanosomabruceirhodesiense
AT christopherkariukikinyanjui il6isupregulatedinlatestagediseaseinmonkeysexperimentallyinfectedwithtrypanosomabruceirhodesiense
AT simonmuturikaranja il6isupregulatedinlatestagediseaseinmonkeysexperimentallyinfectedwithtrypanosomabruceirhodesiense
AT naomiwangarimaina il6isupregulatedinlatestagediseaseinmonkeysexperimentallyinfectedwithtrypanosomabruceirhodesiense
AT mainangotho il6isupregulatedinlatestagediseaseinmonkeysexperimentallyinfectedwithtrypanosomabruceirhodesiense